Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Transcode Therapeutics, Inc. | 70,000 | reported | 14 Jun 2024 | tx 4+134,000 |
| First Tracks Biotherapeutics, Inc. | 15,000 | reported | 12 May 2026 | tx 11+137,134 |
| Arcturus Therapeutics Holdings Inc. | 15,000 | reported | 09 Jun 2025 | tx 12+112,653−3,131 |
| Immix Biopharma, Inc. | 12,500 | reported | 22 May 2026 | tx 11+186,907 |
| ANAPTYSBIO, INC | 11,640 | reported | 15 Jan 2026 | tx 20+121,994−31,930 |
| Pfenex Inc. | 0 | reported | 01 Oct 2020 | tx 4+43,000−43,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 May 2026 | GRANT_AWARD | Immix Biopharma, Inc. | 6,250 | 0.00 USD | |
| 22 May 2026 | GRANT_AWARD | Immix Biopharma, Inc. | 12,500 | 0.00 USD | deriv |
| 12 May 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 12 May 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 42,000 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 784 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 11,000 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 9,200 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 10,600 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 5,500 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 6,030 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 4,000 | 0.00 USD | deriv |
| 15 Jan 2026 | SALE | ANAPTYSBIO, INC | 9,290 | 48.12 USD | |
| 15 Jan 2026 | SALE | ANAPTYSBIO, INC | 1,710 | 48.85 USD | |
| 15 Jan 2026 | EXERCISE | ANAPTYSBIO, INC | 11,000 | 26.11 USD | |
| 15 Jan 2026 | EXERCISE | ANAPTYSBIO, INC | 11,000 | 0.00 USD | deriv |
| 06 Jan 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 5,500 | 0.00 USD | deriv |
| 06 Jan 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 4,000 | 0.00 USD | deriv |
| 20 Jun 2025 | GRANT_AWARD | Immix Biopharma, Inc. | 33,000 | 0.00 USD | deriv |
| 15 Jun 2025 | EXERCISE | ANAPTYSBIO, INC | 6,030 | 0.00 USD | |
| 15 Jun 2025 | EXERCISE | ANAPTYSBIO, INC | 6,030 | 0.00 USD | deriv |
| 09 Jun 2025 | GRANT_AWARD | Arcturus Therapeutics Holdings Inc. | 15,000 | 0.00 USD | deriv |
| 07 Jan 2025 | GRANT_AWARD | ANAPTYSBIO, INC | 6,030 | 0.00 USD | deriv |
| 07 Jan 2025 | GRANT_AWARD | ANAPTYSBIO, INC | 16,510 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 15 Dec 2022.